Hutchmed (China)
HCM
DexCom
DXCM
New Fortress Energy
NFE
eBay
EBAY
Dorian LPG
LPG
US Stock MarketDetailed Quotes
EDIT Editas Medicine
- 1.350
- +0.035+2.66%
Trading Mar 19 12:43 ET
112.02MMarket Cap-0.47P/E (TTM)
1.380High1.320Low500.53KVolume1.330Open1.315Pre Close670.13KTurnover0.61%Turnover RatioLossP/E (Static)82.98MShares7.59552wk High0.83P/B111.54MFloat Cap1.12052wk Low--Dividend TTM82.62MShs Float99.950Historical High--Div YieldTTM4.56%Amplitude1.120Historical Low1.338Avg Price1Lot Size
About Editas Medicine Company
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.
Company Profile
SymbolEDIT
Company NameEditas Medicine
Listing DateFeb 3, 2016
Issue Price16.00
Founded2013
CEODr. Gilmore O’Neill, M.B.
MarketNASDAQ
Employees246
Fiscal Year Ends12-31
Address11 Hurley Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02141
Phone1-617-401-9000
Company Executives
- Name
- Position
- Salary
- Dr. Gilmore O’Neill, M.B.
- Director, Chief Executive Officer and President
- 2.39M
- Linda Burkly
- Executive Vice President and Chief Scientific Officer
- 1.54M
- Erick J. Lucera, C.F.A.
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 2.22M
- Dr. Jessica Hopfield, PhD
- Chairman of the Board
- 231.07K
- Bernadette M. Connaughton
- Independent Director
- 215.06K
- Dr. Elliott M. Levy, M.D.
- Independent Director
- 264.88K
- Andrew J. Hirsch
- Independent Director
- 210.56K
- Dr. David T. Scadden, M.D.
- Independent Director
- 213.06K
